Windlas Biotech - Quaterly Results

20 May 2024 Evaluate
The company witnessed a 21.73% growth in the revenue at Rs. 1712.85 millions for the quarter ended March 2024 as compared to Rs. 1407.13 millions during the year-ago period.A good growth in profit of 48.05% reported to Rs. 169.49  millions over Rs. 114.48 millions of corresponding previous quarter.Operating profit surged to 263.75 millions from the corresponding previous quarter of 187.77 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 1712.85 1407.13 21.73 6309.56 5130.83 22.97 6309.56 5130.83 22.97
Other Income 44.40 23.34 90.23 134.68 99.65 35.15 134.68 99.65 35.15
PBIDT 263.75 187.77 40.46 915.70 702.07 30.43 915.70 702.07 30.43
Interest 2.76 1.64 68.29 11.03 7.86 40.33 11.03 7.86 40.33
PBDT 260.99 186.13 40.22 904.67 694.21 30.32 904.67 694.21 30.32
Depreciation 35.36 35.68 -0.90 134.44 123.64 8.74 134.44 123.64 8.74
PBT 225.63 150.45 49.97 770.23 570.57 34.99 770.23 570.57 34.99
TAX 56.14 35.97 56.07 188.79 144.13 30.99 188.79 144.13 30.99
Deferred Tax 10.93 -6.12 -278.59 15.35 0.63 2336.51 15.35 0.63 2336.51
PAT 169.49 114.48 48.05 581.44 426.44 36.35 581.44 426.44 36.35
Equity 103.99 104.63 -0.61 103.99 104.63 -0.61 103.99 104.63 -0.61
PBIDTM(%) 15.40 13.34 15.39 14.51 13.68 6.06 14.51 13.68 6.06

Windlas Biotech Share Price

632.10 -0.15 (-0.02%)
03-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1453.25
Dr. Reddys Lab 5792.95
Cipla 1459.85
Zydus Lifesciences 1032.25
Lupin 1583.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.